EPIEN MEDICAL, INC. Contracts & Agreements
26 Contracts & Agreements
- Business Finance (14 contracts)
- Human Resources (6)
- Real Estate (2)
- Uncategorized (4)
- Form of Underwriting Agreement (Filed With SEC on September 30, 2022)
- Form of Representatives Warrant (Filed With SEC on September 30, 2022)
- Form of Common Stock Purchase Warrant in this Offering (Filed With SEC on September 30, 2022)
- Form of Warrant Agent Agreement between EPIEN Medical, Inc. and VStock Transfer, LLC (Filed With SEC on September 30, 2022)
- Form of Standard Investor Warrant (Filed With SEC on September 30, 2022)
- Form of Investor Warrant for 2005 Bridge Financing (Filed With SEC on September 30, 2022)
- Form of Convertible Promissory Note for 2005 Bridge Financing (Filed With SEC on September 30, 2022)
- Form of Investor Warrant for 2021 Bridge Financing (Filed With SEC on September 30, 2022)
- Form of Poppleton Warrant for 2021 Bridge Financing (Filed With SEC on September 30, 2022)
- Form of Convertible Promissory Note for 2021 Bridge Financing (Filed With SEC on September 30, 2022)
- Stock Option Plan (1998) (Filed With SEC on September 30, 2022)
- Form of Subscription Documents for 2005 Bridge Financing (Filed With SEC on September 30, 2022)
- Form of Subscription Documents for 2021 Bridge Financing (Filed With SEC on September 30, 2022)
- Old National Bank Commercial Credit (Filed With SEC on September 30, 2022)
- Lease Agreement for 4225 White Bear Parkway (Filed With SEC on September 30, 2022)
- Lease Agreement for 600 Highway 169 South (Filed With SEC on September 30, 2022)
- Employment Agreement with Reginald R.Dupre (Filed With SEC on September 30, 2022)
- Employment Agreement with Michael Basara (Filed With SEC on September 30, 2022)
- Employment Agreement with Steven Kavros (Filed With SEC on September 30, 2022)
- Employment Agreement with David Ufheil (Filed With SEC on September 30, 2022)
- EPIEN Medical, Inc. Equity Incentive Plan (2022) (Filed With SEC on September 30, 2022)
- EPIEN Medical, Inc. Key Employee/Executive Severance and Change of Control Plan (Filed With SEC on September 30, 2022)
- Research Agreement with the University of Miami, dated January 11, 2022, Effects of Revity on Dermatophytes Using a Porcine Model (Filed With SEC on September 30, 2022)
- Amendment No. 1 to Research Agreement with the University of Miami, dated January 11, 2022, Effects of Revity on Dermatophytes Using a Porcine Model (Filed With SEC on September 30, 2022)
- Research Agreement with the University of Miami, dated August 20, 2021, Determination of the Debridement Effects of Revity on Deep Dermal Wounds (Filed With SEC on September 30, 2022)
- Research Agreement with the University of Miami, dated June 1, 2022, Evaluation of the effects of HYBENX solution on human squamous cell carcinoma in mouse xenograft model in vivo (Filed With SEC on September 30, 2022)
